Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
New from Innovative Science Press is Survival Guide to Dermatopathology by Jerad M. Gardner, MD. Dr. Gardner covers many of the common entities in dermatopathology as well as some esoteric ones, particularly if they have distinct features or are of major clinical significance, in order to help the reader increase diagnostic confidence. The guide features numerous high-quality photomicrographs annotated with key findings.
Donald A. B. Lindberg, MD, former director of the National Library of Medicine, passed away on August 17. Past member of the CAP, Dr. Lindberg graduated from Columbia University College of Physicians and Surgeons in 1958 and was a professor of information science and professor of pathology at the University of Missouri-Columbia before being named director of the NLM in 1984. Read his New York Times obituary.
Executives at data analytics firm Diaceutics have written an article titled “Diagnostics reform and harmonization of clinical laboratory testing” in the Journal of Molecular Diagnostics.
Barbarajean (BJ) Magnani, PhD, MD, chief of clinical pathology and director of toxicology at Tufts Medical Center, has released her second book, a medical thriller featuring protagonist Dr. Lily Robinson.
George D. Lundberg, MD, addresses that question and more in a recent JAMA Network Open commentary to “Trends in the US and Canadian pathologist workforces from 2007 to 2017.”
The Cancer Biomarkers Conference series provides real-world practical updates for general community pathologists, molecular pathologists, oncologists, and related specialties and professions.
A white paper titled “Can Global Testing for C. difficile Carriers Help to Prevent Healthcare-associated CDI?” from Luminex discusses the results of two recent studies that show that performing C. difficile testing only in patients with clinically significant diarrhea may be missing an opportunity to prevent CDI transmission from asymptomatic carriers. Download the white paper.
A new white paper titled “The CMS National Coverage Decision on NGS” from Diaceutics provides coverage of ongoing developments since the NGS national coverage decision was made. Read the white paper (requires free registration).
In a collaborative effort to discuss the future of the laboratory in health care, Bob McGonnagle, publisher of CAP TODAY, gathered with Orchard Software’s Curt Johnson, chief operating officer, and Matt Modleski, chief operating officer, American Health Network.
Improve triaging in the ED: A new assay delivers a higher standard of cardiac care. “Is it a heart attack, or something less serious?” Every day, thousands of symptomatic patients ask emergency department (ED) physicians that very question. Over the years, as diagnostic tools for acute myocardial infarction (AMI), commonly known as a heart attack, have advanced, physicians can provide increasingly accurate answers to that question. Unfortunately, diagnostic gaps still exist that can result in poor patient outcomes.
